Koers Stellar Biotechnologies Inc Toronto S.E.
Aandelen
KLH
CA85855A2039
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 14,57 mln. 19,83 mln. 13,41 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -10,89 mln. -7,36 mln. | Nettowinst (verlies) 2025 * | -10 mln. -13,61 mln. -9,2 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,62
x | K/w-verhouding 2025 * |
-2,72
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 71,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Michael Brooks
PSD | President | 46 | 01-09-15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15-07-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07-06-19 |
Frank Oakes
BRD | Director/Board Member | 73 | 09-04-10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,33% | 111 mld. | |
+12,11% | 106 mld. | |
-12,56% | 22,24 mld. | |
-3,49% | 21,25 mld. | |
-5,52% | 18,97 mld. | |
-35,21% | 18,52 mld. | |
-10,86% | 16,81 mld. | |
+37,57% | 12,54 mld. | |
-26,24% | 8,09 mld. |